Nexalin Technology, Inc. Common Stock
Symbol: NXL (NASDAQ)
1.51
▼ (-1.95%) -0.030
Company Description:
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
Key Stats
- Today's Open: $1.5
- Today's High: $1.555
- Today's Low: $1.325
- Today's Volume: 479.06K
- Yesterday Close: $1.54
- Yesterday High: $1.69
- Yesterday Low: $1.5
- Yesterday Volume: 1.07M
- Last Min Volume: 1.00K
- Last Min High: $1.51
- Last Min Low: $1.51
- Last Min VWAP: $1.51
Company Profile
- Name: Nexalin Technology, Inc. Common Stock
- Website: https://www.nexalin.com
- Listed Date: 2022-09-16
- Location: HOUSTON, TX
- Market Status: Active
- CIK Number: 0001527352
- SIC Code: 3845
- SIC description: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
- Market Cap: $28.01M
- Round Lot: 100
- Outstanding Shares: 18.19M
- Asset Type: CS
RECENT FILINGS FOR NXL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-15 | 8-K | View |
| 2025-10-15 | 424B5 | View |
| 2025-09-30 | 4 | View |
| 2025-09-30 | 4 | View |
| 2025-09-30 | 4 | View |
| 2025-09-30 | 4 | View |
| 2025-09-23 | 10-K/A | View |
| 2025-09-22 | 8-K | View |
| 2025-09-19 | 25-NSE | View |
| 2025-09-12 | 4 | View |
| 2025-09-12 | 4 | View |
| 2025-09-12 | 4 | View |
| 2025-09-10 | 144 | View |
| 2025-08-07 | 3 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-04 | 8-K | View |
| 2025-07-21 | 8-K | View |
| 2025-07-21 | 4 | View |
| 2025-07-17 | 8-K | View |
| 2025-06-17 | DEF 14A | View |
Latest News on NXL